Brovana Related Clinical Trials
Study of Arformoterol Tartrate Inhalation Solution and Racemic Formoterol in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) [Completed]
A Dose Ranging Study of Arformoterol Given Once Daily Compared to Arformoterol Given Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Relative Bronchodilating Effects of Formoterol When Administered Via Symbicort Pressurized Metered-Dose Inhaler (pMDI) or Oxis Turbuhaler [Completed]
A Pivotal Study of the Safety and Effectiveness of Arformoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD [Completed]
Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®) [Completed]
To Evaluate the Long-Term Safety of (R,R)-Formoterol in Subjects With COPD [Completed]
Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease [Completed]
Formoterol Certihaler, Tiotropium HandiHaler and Tiotropium HandiHaler in Combination With Formoterol Certihaler in Patients With Stable Chronic Obstructive Pulmonary Disease [Completed]
Efficacy Safety Study of Arformoterol/Tio Combo vs. Either Therapy Alone in COPD [Completed]
Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04334AM1) [Active, not recruiting]
Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04073AM1) [Active, not recruiting]
Study of Mometasone Furoate/Formoterol Fumarate Inhalation Combination in Healthy Volunteers [Completed]
Perforomist vs. Foradil Evaluated by Inspiratory Capacity and High Resolution Computed Tomography (HRCT) [Not yet recruiting]
Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients With COPD [Active, not recruiting]
Study to Demonstrate Equivalence of Formoterol 12 and 24 µg Delivered Via Two Types of Single Dose Dry Powder Inhalers (Concept1 and Aerolizer) [Completed]
Bronchoprotective Effect of Arformoterol in Children With Exercise-Induced Bronchospasm (EIB) [Recruiting]
SMILDA - Symbicort®Turbuhaler® Allergan Challenge Study in Allergic Patients With Mild Asthma [Completed]
Single Dose Study of the Effect of Formoterol Fumarate in Combination With Mometasone Furoate Inhaled Via a Pressurized Metered Dose Inhaler (pMDI) in Children Aged 5-11 Years Old With Persistent Asthma [Recruiting]
Comparison of Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Recruiting]
Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in COPD (Study P04229AM4) [Recruiting]
Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in Chronic Obstructive Pulmonary Disease (COPD) (Study P04230AM4) [Recruiting]
Evaluation of Efficacy and Safety of Formoterol in Patients With COPD Compared With Placebo in Patients in Japan, EU [Recruiting]
Efficacy Safety Study of Arformoterol QD Dosing Versus BID Dosing in COPD [Completed]
A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects [Recruiting]
Effect of Budesonide / Formoterol Combination in Repeated AMP Provocations [Completed]
A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD Patients [Completed]
Effect of Brovana and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD) [Recruiting]
Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone & Formoterol Administered Alone in Patients With Asthma [Completed]
Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma [Completed]
New Combination Inhaler (Flutiform HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma [Active, not recruiting]
Safety and Tolerability of Ciclesonide and Formoterol Fumarate Inhaled Once Daily in Patients With Asthma (18 to 75 y) (BY9010/M1-506) [Completed]
Asthma Study Comparing Anti-Inflammatory Effects of 3 Doses of Mometasone Furoate/Formoterol Fumarate and Medium Dose Mometasone Furoate (Study P05122 AM1) [Recruiting]
Evaluation of Efficacy on Exercise Tolerance of Symbicort (Budesonide/Formoterol) Compared to Placebo and Oxis in Patients With Severe COPD [Recruiting]
Dose-Response of Inhaled Formoterol [Not yet recruiting]
Study to Evaluate the Additional Effects of Tiotropium Plus Formoterol on Chronic Obstructive Pulmonary Disease (COPD) During Exercise [Recruiting]
Symbicort in Asthmatic Children - SEEDLING [Completed]
Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 80/4.5 [Completed]
Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 160/4.5 [Completed]
Effects of Bronchodilator on Exercise Endurance Time and Breathlessness in Chronic Obstructive Pulmonary Disease (COPD): Cycle Ergometry Versus Treadmill [Recruiting]
Comparison Between Symbicort® and Prednisolone in COPD [Completed]
Aclidinium/Formoterol Fixed Combination Dose Finding Study [Recruiting]
A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD [Completed]
Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04431AM2)(COMPLETED) [Completed]
EFFICACY AND TOLERABILITY OF BECLOMETHASONE DIPROPIONATE 100 µg + FORMOTEROL 6 µg pMDI VIA HFA-134a vs. FLUTICASONE 125 µg + SALMETEROL 25 µg pMDI [Completed]
Prospective Evaluation of the Efficacy of Budesonide/Formoterol in Bronchiolitis Obliterans in AHSCT [Not yet recruiting]
A Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPD [Recruiting]
A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate 20 Mcg/0.5 mL in the Treatment of Patients With COPD
Efficacy of Formoterol vs Ipatropioum Bromide Plus Fenoterol in Children (5-<12 Years) With Acute Bronchial Obstruction [Recruiting]
Study of FlutiForm® Versus Fluticasone Plus Formoterol in Adult Subjects With Severe Asthma [Recruiting]
Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272) (COMPLETED) [Completed]
An Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy and Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent and Adult Subjects With Mild to Moderate-Severe Persistent, Reversible Asthma [Completed]
Influence Of Different Airflow Resistances On Drug Effect Of 50μg Salmeterol And 6 μg Formoterol [Completed]
Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler in Patients With Moderate to Severe Persistent Asthma [Completed]
Budesonide / Formoterol in Treatment of Exacerbations of COPD
Clinical Trial of the Efficacy and Safety of Beclomethasone Dipropionate Plus Formoterol vs Fluticasone Propionate Plus Salmeterol in the 6 Months Step Down Treatment of Asthma [Recruiting]
A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate in the Treatment of Patients With COPD [Completed]
A 3-Week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma [Completed]
Efficacy, Safety and Tolerability of Once-Daily (o.d.) Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) Using Formoterol Twice Daily (b.i.d.) as Active Control
A Six-Week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in COPD [Completed]
Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol [Recruiting]
A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPD [Completed]
CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE With An Adjustable Maintenance Dose Of SYMBICORT [Completed]
Study of the Effects of Different Long-Acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations [Recruiting]
A Study Evaluating Systemic Exposure and Pharmacodynamics in Patients With Chronic Obstructive Pulmonary Disease [Not yet recruiting]
A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiFormâ„¢) With Fluticasone or Flovent to Treat Moderate to Severe Asthma in Adolescents and Adults [Recruiting]
Single-Dose Crossover Study to Investigate Pharmacodynamics of AZD3199 [Recruiting]
Metoprolol and Formoterol in Chronic Obstructive Pulmonary Disease (COPD) [Recruiting]
Study of Inhaled Glucocorticosteroids/Long-Acting Bronchodilator Drugs in Subjects With Asthma That Have Been Taking Inhaled Glucocorticosteroids (Study P04705AM1) [Recruiting]
Mechanism(s)of Airflow Limitation in Moderate-Severe Persistent Asthma [Recruiting]
Single-Dose Crossover Study to Evaluate the Early Bronchodilating Effect of FlutiForm HFA pMDI in Adult Subjects With Mild to Moderate Asthma [Recruiting]
Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily Practice [Recruiting]
A Patient Handling Study of MF/F MDI With an Integrated Dose Counter in Adolescent and Adult Subjects With Asthma or Chronic Obstructive Pulmonary Disease (Study P04703) [Recruiting]
A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma [Recruiting]
Asthma Control-A "Patient Follow up Programme" Maintenance and Reliever Therapy in a Single Inhaler [Recruiting]
A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiFormâ„¢ on the Amount, if Any, of Cortisol Produced by the Adrenal Glands [Recruiting]
Phase4/Symbicort Versus Pulmicort Flexhaler in African Americans [Recruiting]
The Effect of Left Ventricular Filling Pressure on Pulmonary Clearance of Free Radical Loaded White Blood Cells and Platelets in Congestive Heart Failure Patients Before and After Biventricular Pacing [Not yet recruiting]
A Comparison of SYMBICORT pMDI With Budesonide HFA pMDI in African American Subjects With Asthma. [Recruiting]
Evaluation of Onset of Effect in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD) Treated With Symbicort Compared to Seretide [Recruiting]
Theophylline in Chronic Obstructive Pulmonary Disease [Recruiting]
A Phase 3, Multicenter, Open-Label Continuation Study in Moderate to Severe Asthmatic Subjects Who Completed FlutiForm HFA pMDI Study SKY2028-3-005 [Recruiting]
Long-Term Oxygen Therapy (LTOT) in Chronic Obstructive Pulmonary Disease (COPD) Patients With Moderate Chronic Hypoxemia and Chronic Heart Failure (CHF) [Not yet recruiting]
|
